Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Surface Logix Completes $25M Round For Drug Discovery Work

Nov. 27, 2002

By Aaron Lorenzo

Biotech Veterans Bring In $13.6M To Fund Seattle-Based GeneCraft

Nov. 26, 2002

By Aaron Lorenzo

Biotech Veterans Bring In $13.6M To Fund Seattle-Based GeneCraft

Nov. 26, 2002

By Aaron Lorenzo

Inspire Starts Phase III Trial Of Drug For Allergic Rhinitis

Nov. 22, 2002

By Aaron Lorenzo

Inflazyme In Line For Up To $90M After Expanding Deal With Aventis

Nov. 22, 2002

By Aaron Lorenzo

Inflazyme In Line For Up To $90M After Expanding Deal With Aventis

Nov. 22, 2002

By Aaron Lorenzo

Inspire Starts Phase III Trial Of Drug For Allergic Rhinitis

Nov. 22, 2002

By Aaron Lorenzo

Palatin Raises $11.5M For LeuTech, PT-141 Progress

Nov. 21, 2002

By Aaron Lorenzo

Palatin Raises $11.5M For LeuTech, PT-141 Progress

Nov. 21, 2002

By Aaron Lorenzo

Psychiatric Genomics Raises $17M As Part Of Series B Round

Nov. 20, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...